My Blue Dots

BAAR, Switzerland–(BUSINESS WIRE)—- $NVCR–Novocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company Update

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced updated topline Phase 1 combination data for zelenectide pevedotin plus pembrolizumab in previously untreated (first-line) cisplatin-ineligible patients with metastatic urothelial cancer (mUC). The company also announced recent accomplishments and

TAMPA, Fla.–(BUSINESS WIRE)–Smart Meter, the leading technology and infrastructure supplier to the remote patient monitoring (RPM) industry, is thrilled to announce significant milestones in its growth trajectory. Since 2022, the company has achieved a remarkable 300% increase in sales, quadrupled its commercial customer base, and over 350,000 patients currently have Smart Meter solutions. To accommodate this rapid growth, Smart Meter has moved into a new 25,000 square foot logistics, network

NEW YORK–(BUSINESS WIRE)–Schrödinger, Inc. (Nasdaq: SDGR) today provided an update on its progress across the business in 2024 and announced its strategic priorities for 2025. “We are very proud of our accomplishments in 2024. We advanced the capabilities of our computational platform and leveraged the synergies in our business, which included signing a multi-target research collaboration and expanded software licensing agreement with Novartis. We are pleased another innovative pharmaceutical

NEW YORK–(BUSINESS WIRE)–Qventus, a leading provider of AI-based care automation software for health systems, today announced a $105 million investment led by global investment firm KKR, with additional participation from world-renowned investment firm Bessemer Venture Partners, and new strategic investors, including leading health systems Northwestern Medicine, HonorHealth, and Allina Health. Qventus has built an AI-first care operations automation platform deployed across leading health sys

BOSTON & LONDON–(BUSINESS WIRE)–TA Associates (“TA” or the “Firm”), a leading global private equity firm, announced today that its holding company, Project Neptune BidCo GmbH, successfully completed its tender offer (the “Offer”) to acquire all outstanding ordinary shares and stock acquisition rights of Nexus AG (“Nexus”), a leading European software company in the e-health sector. This transaction, undertaken in partnership with the Management Board of Nexus, marks a significant milestone in

NASSAU, Bahamas–(BUSINESS WIRE)–OneSpaWorld Holdings Limited, (NASDAQ: OSW), the pre-eminent global provider of health and wellness products and services on board cruise ships and in destination resorts around the world, today is providing preliminary revenue and Adjusted EBITDA expectations for Fiscal Year 2024 and introducing select Fiscal Year 2025 guidance. The Company is providing this update ahead of investor meetings and its fireside chat presentation at the ICR Conference 2025. Leonar

NEW BRUNSWICK, N.J. & BEDMINSTER, N.J.–(BUSINESS WIRE)–Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced today that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, for $132.00 per share in cash for a total equity value

OKLAHOMA CITY & TORRANCE, Calif.–(BUSINESS WIRE)–This new collaboration provides a scalable, integrated solution for developing and manufacturing complex peptide drugs efficiently.

SAN DIEGO–(BUSINESS WIRE)– #biobam–BioBam, a leading bioinformatics solutions provider, proudly presents OmicsBox Version 3.4 at the San Diego Plant and Animal Genome Conference (PAG 32). This latest release introduces a range of enhancements designed to address the evolving needs of modern genomics and transcriptomics research. A key highlight of OmicsBox 3.4 is the integration of CellKB, a robust cell-type prediction tool for single-cell RNA sequencing (scRNA-Seq) analysis. CellKB streamlines scRNA-